Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 1475 entries
View as:

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03363776 Org: User:
Start: 12/06/17 End: 11/22/19 Due: 11/22/20

Study of Nivolumab Given Sequentially With Ipilimumab in Subjects With Advanced or Metastatic Melanoma (CheckMate 064)

Phase: N/A Priority: Normal
NCT ID: NCT01783938 Org: User:
Start: 04/30/13 End: 08/12/20 Due: 08/12/21

Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00279734 Org: User:
Start: 08/31/04 End: 01/31/05 Due: 01/31/06

Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00982488 Org: User:
Start: 10/31/07 End: 12/31/14 Due: 12/31/15

Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01108705 Org: User:
Start: 05/31/10 End: 10/31/13 Due: 10/31/14

A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)

Phase: N/A Priority: Normal
NCT ID: NCT03407105 Org: User:
Start: 04/21/03 End: 02/21/06 Due: 02/21/07

A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

Phase: N/A Priority: Normal
NCT ID: NCT02673489 Org: User:
Start: 03/15/16 End: 05/26/17 Due: 05/26/18

Study of Nivolumab for Advanced Cancers in India

Phase: N/A Priority: Normal
NCT ID: NCT03444766 Org: User:
Start: 03/06/18 End: 07/17/19 Due: 07/17/20

A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring

Phase: N/A Priority: Normal
NCT ID: NCT06710470 Org: User:
Start: 08/02/24 End: 02/28/29 Due: 02/28/30

An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic

Phase: N/A Priority: Normal
NCT ID: NCT03730961 Org: User:
Start: 01/17/19 End: 01/09/20 Due: 01/09/21

Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database

Phase: N/A Priority: Normal
NCT ID: NCT05426239 Org: User:
Start: 01/09/19 End: 09/07/20 Due: 09/07/21

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04567615 Org: User:
Start: 02/05/21 End: 10/03/25 Due: 10/03/26

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00989235 Org: User:
Start: 04/30/07 End: 10/31/09 Due: 10/31/10

Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER

Phase: N/A Priority: Normal
NCT ID: NCT03496168 Org: User:
Start: 04/26/18 End: 11/09/23 Due: 11/09/24

A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00057473 Org: User:
Start: 02/28/03 End: 02/29/04 Due: 02/28/05

Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03349710 Org: User:
Start: 12/15/17 End: 10/14/19 Due: 10/14/20

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986308 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04763226 Org: User:
Start: 04/14/21 End: 02/27/22 Due: 02/27/23

Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00971945 Org: User:
Start: 06/30/05 End: 03/31/08 Due: 03/31/09

A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00329004 Org: User:
Start: 08/31/06 End: 07/31/09 Due: 07/31/10

A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT04810078 Org: User:
Start: 05/21/21 End: 05/10/27 Due: 05/10/28

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05470985 Org: User:
Start: 08/22/23 End: 09/13/24 Due: 09/13/25

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01079806 Org: User:
Start: 06/30/10 End: 03/31/18 Due: 03/31/19

A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05169684 Org: User:
Start: 02/14/22 End: 12/06/23 Due: 12/06/24

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT05664737 Org: User:
Start: 12/09/22 End: 08/14/34 Due: 08/14/35

Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada

Phase: N/A Priority: Normal
NCT ID: NCT06361563 Org: User:
Start: 09/05/23 End: 01/25/24 Due: 01/25/25